OGI · Organigram Global Inc.

Organigram Global Inc. has completed its strategic acquisition of Sanity Group GmbH, a leading European cannabis company with operations across Germany, Switzerland, the United Kingdom, Poland, and Czechia. The transaction significantly expands Organigram's international footprint and provides immediate access to Sanity's established European platform, regulatory expertise, and distribution capabilities across medical cannabis, recreational pilot programs, and wellbeing products. The financing structure demonstrates BAT's continued strategic support, with the private placement providing €40.3 million and the investor opting to take shares rather than cash for its Sanity interest. The senior secured credit facilities from ATB Financial provide additional financial flexibility, with the C$20 million term loan drawn at closing to partially fund the acquisition. The earnout structure aligns seller incentives with Sanity's future performance, with up to €113.8 million in additional consideration available based on financial results through April 2027. This acquisition represents the final deployment of Organigram's Jupiter strategic investment pool established with BAT funding in 2024, marking a significant milestone in the company's international growth strategy.